Vildagliptin Carboxylic Acid Metabolite (CAS 565453-40-9)

Vildagliptin Carboxylic Acid Metabolite (VCAM) serves as a investigative tool in the study of dipeptidyl peptidase-4 (DPP-4) enzyme mechanisms, due to its pivotal role as a metabolite of vildagliptin. Vildagliptin Carboxylic Acid Metabolite is extensively used in research applications to explore the biochemical pathways and enzymatic reactions associated with the modulation of DPP-4 activity. It functions by binding to the active site of the DPP-4 enzyme, demonstrating a competitive inhibition that is valuable in elucidating the enzyme′s substrate specificity and kinetic properties. This metabolite is particularly significant in the context of diabetes research, as DPP-4 plays a key role in glucose metabolism by influencing the levels of incretin hormones, which are critical in regulating insulin secretion. Research involving Vildagliptin Carboxylic Acid Metabolite helps in understanding the metabolic pathways that influence the activity of DPP-4 and the broader implications for energy homeostasis and glucose regulation. This understanding is vital for advancing knowledge in biochemical pharmacology and the development of novel approaches to managing metabolic disorders.